Glucocorticoids as Mediators of Adverse Outcomes of Prenatal Stress

Trends Neurosci. 2020 Jun;43(6):394-405. doi: 10.1016/j.tins.2020.03.008. Epub 2020 Apr 15.

Abstract

A number of prenatal experiences are associated with adverse outcomes after birth, ranging from cardiovascular problems to psychiatric disease. Prenatal stress is associated with neurodevelopmental alterations that persist after birth and manifest at the behavioral level, for example, increased fearfulness, and at the physiological one, that is, brain structural and functional changes. Understanding the mechanisms that drive these lasting effects may help in preventing long-term negative outcomes of prenatal stress. Elevated glucocorticoid signaling in utero may be one of the key mediators of prenatal stress effects on the offspring. In this review, we summarize how prenatal glucocorticoids may impact the activity of the fetal hypothalamic-pituitary-adrenal (HPA) axis, disrupt neurodevelopmental processes and alter the epigenetic landscape of the fetus. We also discuss the need to take into consideration the interaction of these processes with the offspring's genetic landscape.

Keywords: epigenetics; glucocorticoids; neurodevelopment; placenta; programming; stress.

Publication types

  • Review

MeSH terms

  • Female
  • Glucocorticoids*
  • Humans
  • Hypothalamo-Hypophyseal System
  • Pituitary-Adrenal System
  • Placenta
  • Pregnancy
  • Prenatal Exposure Delayed Effects*

Substances

  • Glucocorticoids